FDA signs off on change to contraindications for GE's Optison agent

The U.S. Food and Drug Administration (FDA) has approved the removal of hypersensitivit...Read more on AuntMinnie.comRelated Reading: Experts call for expanded use of ultrasound contrast agents GE rolls out MyoSPECT cardiac nuclear medicine scanner GE releases new fixed digital x-ray system GE to acquire ultrasound firm BK Medical for $1.5B Contrast group asks FDA to pull 'black box' warning
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news